Search database
LIST OPTIONS
Filter
20
Filtered Results: 20
Text search: B. Dongmo-Nguimfack
Featured
Language
Document type
No document type
12
Guidelines
4
Studies & Reports
3
Manuals
1
Countries / Regions
Global
1
Africa
1
Authors & Publishers
World Health Organization
5
World Health Organization WHO
5
et al.
3
PLOS One
2
World Health Organization (WHO)
2
A. Adesina
1
A. Bokazhanova
1
A. Gupta
1
A. J. Shattock
1
Action Against Hunger
1
B. Dongmo-Nguimfack
1
C. Benedikt
1
D. Jamieson
1
Elaine Abrams, Tsitsi Apollo, Janet Bhila et al.
1
Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al.
1
J. Stover
1
JIAS ( Journal of the International AIDS Society)
1
Journal of Movements Disorders
1
M. Auton
1
M. Vitoria
1
O. Bandmann
1
Organisation mondiale de la Santé
1
Organización Mundial de la Salud (Americas)
1
Organización Panamericana de la Salud
1
R. Walker
1
S. E. Kellerman
1
S. Juneja
1
U. Williams
1
UNITAID
1
WHO
1
Publication Years
Category
HIV & STI
5
Virology
2
Communicable Diseases
1
Hepatitis
1
Under-5 nutrition
1
Toolboxes
Clinical Aspects, Treatment & Prevention
7
Antiretroviral Treatment ART
7
Access to treatment and laboratory
5
Treatment Guidelines HIV
4
HIV testing & services
2
TB/HIV Coinfection
2
General Reports
1
Treatment & Prevention
1
Clinical Aspects
1
Opportunistic Infections
1
Prevention Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Supply Chain & Store Management
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Neurological Disorders
1
HIV service delivery
1
Reports & Studies
1
Neurological disorders, Others
1
Eastern Europe and central Asia
1
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection HIV Treatment
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,... more
July 2018 This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... more
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ... more
J Mov Disord > Volume 11(2); 2018 > Article Review Article J Mov Disord 2018; 11(2): 53-64. Published online: May 30, 2018 DOI: https://doi.org/10.14802/jmd.17028
Technical Report AIDS Medicines and diagnostics service July 2015
WHO/HIV/SIP Accessed: 28.11.2019
Technical Report AIDS Medicines and diagnostics service September 2016

Directrices unificadas sobre el uso de los antirretrovirales para el tratamiento y la prevención de la infección por el VIH

Organización Panamericana de la Salud; Organización Mundial de la Salud (Americas) (2018) C_WHO
Recomendaciones para un enfoque de salud pública Segunda edición 2016
Jamieson D and Kellerman S. Journal of the International AIDS Society 2016, 19:20917 http://www.jiasociety.org/index.php/jias/article/view/20917 | http://dx.doi.org/10.7448/IAS.19.1.20917
Overcoming barriers in low- and middle-income countries For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha... more
This summary assesses the current state of evidence on each approach in tabular form, providing: the definition and objectives; evidence of effectiveness; operational considerations (e.g., training, staffing, and logistics); cost considerations and evidence on cost-effectiveness; operational success... more
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach. These guidelines bring in... more
The 2030 health-related Sustainable Development Goals call on countries to end AIDS as a public health threat and also to achieve universal health coverage. The World Health Organization (WHO) promotes primary health care (PHC) as the key mechanism for achieving universal health coverage, and the PH... more